Wandercraft closes Series D funding-and-financing package
Wandercraft secured a $75 million Series D funding-and-financing package with major contributions from Renault Group, the PSIM fund managed by Bpifrance, Teampact Ventures and Quadrant Management.
Evidence notes
- The completed Series D package totaled $75 million across funding and financing; component amounts were not disclosed.
- Other participants included LBO France, Mutuelles Impact managed by XAnge, Cemag Invest, Martagon Capital and AG2R LA MONDIALE.
- The package supports Eve commercialization, Atalante X clinical adoption and development and deployment of Calvin-40 and the broader Calvin humanoid family.
Company context
Develops self-balancing robotic exoskeletons designed to restore walking ability for people with mobility impairments. The systems use dynamic stabilization to enable hands-free locomotion without crutches or walkers.